Showing results (11-20 of 114) with videos related to
Sort By:
Pageof 12
Expert Opinion on Therapeutic Targets|March 21, 2023
Parasite and host kinases as targets for antimalarialsHan Wee Ong, Jack Adderley, Andrew B Tobin, et al.Current Research in Chemical Biology|April 6, 2026
Identification of a chemical probe for lipid kinase phosphatidylinositol-5-phosphate 4-kinase gamma (PI5P4Kγ)David H Drewry, Frances M Potjewyd, Jeffery L Smith, et al.Scientific Reports|September 28, 2020
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitorTigist Y Tamir, David H Drewry, Carrow Wells, et al.Cell Reports. Medicine|October 25, 2021
Host-directed therapy, an untapped opportunity for antimalarial interventionLing Wei, Jack Adderley, Didier Leroy, et al.Bioorganic & Medicinal Chemistry Letters|May 9, 2006
Array synthesis of progesterone receptor antagonists: 3-aryl-1,2-diazepinesRobert W Wiethe, Eugene L Stewart, David H Drewry, et al.ACS Chemical Neuroscience|May 29, 2020
Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative DiseasesAndrea I Krahn, Carrow Wells, David H Drewry, et al.International Journal of Molecular Sciences|October 29, 2020
Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3Martin Schröder, Panagis Filippakopoulos, Martin P Schwalm, et al.ACS Chemical Biology|June 30, 2020
Identifying the Target of an Antiparasitic Compound in Toxoplasma Using Thermal Proteome ProfilingAlice L Herneisen, Saima M Sidik, Benedikt M Markus, et al.Plos One|March 19, 2013
Profile of the GSK published protein kinase inhibitor set across ATP-dependent and-independent luciferases: implications for reporter-gene assaysPatricia Dranchak, Ryan MacArthur, Rajarshi Guha, et al.The Biochemical Journal|August 29, 2023
How many kinases are druggable? A review of our current understandingBrian Anderson, Peter Rosston, Han Wee Ong, et al.Pageof 12